1887

Abstract

The therapeutic alternatives available for use against ciprofloxacin-resistant enteric fever isolates in an endemic area are limited. The antibiotics currently available are the quinolones, third-generation cephalosporins and conventional first-line drugs. In this study, the MICs of various newer drugs were determined for 31 ciprofloxacin-resistant enteric fever isolates (26 serovar Typhi and 5 serovar Paratyphi A). MICs for ciprofloxacin, ofloxacin, gatifloxacin, levofloxacin, cefotaxime, cefixime, cefepime and azithromycin were determined using Etest strips and the agar dilution method. By Etest, all of the ciprofloxacin-resistant isolates had ciprofloxacin MICs ≥32 μg ml. Typhi showed MIC values of 0.50, 0.25 and 0.38 μg ml for cefixime, cefotaxime and cefepime, respectively. For the cephalosporins, a negligible difference in MIC and MIC values for Typhi and Paratyphi A was observed. A single isolate of Typhi showed a high azithromycin MIC of 64 μg ml. The MIC value for azithromycin in Typhi and Paratyphi was 24 μg ml. Gatifloxacin demonstrated lower resistance (80.8 %) compared with the other quinolones (92–100 %) in Typhi. The rise in MIC levels of these antimicrobials is a matter for serious concern.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47353-0
2007-11-01
2020-11-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/11/1490.html?itemId=/content/journal/jmm/10.1099/jmm.0.47353-0&mimeType=html&fmt=ahah

References

  1. Butler T., Sirdhar C. B., Daga M. K., Pathak K., Pandit R. B., Khakhria R., Potkar C. N., Zelasky M. T. 1999; Treatment of typhoid fever with azithromycin vs chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 44:243–250 [CrossRef]
    [Google Scholar]
  2. Capoor M. R., Nair D., Hasan A. S., Aggarwal P., Gupta B. 2006; Narrowing therapeutic options in typhoid fever, India. Southeast Asian J Trop Med Public Health 37:1170–1174
    [Google Scholar]
  3. CLSI 2006 Performance Standards for Antimicrobial Susceptibility Testing , 16th information supplement, M100-S16 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  4. Cooke F. J., Wain J., Threlfall E. J. 2006; Fluoroquinolone resistance in Salmonella enterica serovar Typhi. BMJ 333:353–354
    [Google Scholar]
  5. Frenck R. W. Jr, Mansour A., Nakhla I., Sultan Y., Putnam S., Wierzba T., Morsy M., Knirsch C. 2004; Short course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 38:951–957 [CrossRef]
    [Google Scholar]
  6. Gaind R., Paglietti B., Murgia M., Dawar R., Uzzau S., Cappuccinnelli P., Deb M., Aggarwal P., Rubino S. 2006; Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemother 58:1139–1144 [CrossRef]
    [Google Scholar]
  7. Girgis N. I., Butler T., Frenck R. W., Sultan Y., Brown F. M., Tribble D., Johnson R. B., Khakhria R. 1999; Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 43:1441–1444
    [Google Scholar]
  8. Gordillo M. E., Singh K. V., Murray B. F. 1993; In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother 37:1203–1205 [CrossRef]
    [Google Scholar]
  9. Kownhar H., Shankar E. M., Rajan R., Rao U. A. 2007; Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol 56:136–137 [CrossRef]
    [Google Scholar]
  10. Parry C. M. 2004; The treatment of multidrug resistant and nalidixic acid resistant typhoid fever in Vietnam. Trans R Soc Trop Med Hyg 98:413–423 [CrossRef]
    [Google Scholar]
  11. Parry C. M., Ho V. A., Phuong L. T., Bay P. V., Lanh M. N., Tung L. T., Tham N. T., Wain J., Hien T. T. 2007; A randomized controlled comparison of ofloxacin, azithromycin and ofloxacin-azithromycin combination for treatment of multidrug resistant and nalidixic acid resistant typhoid fever. Antimicrob Agents Chemother 51:819–825 [CrossRef]
    [Google Scholar]
  12. Pokharel B. M., Koirala J., Dahal R. K., Mishra S. K., Khadga P. K., Tuladhar N. R. 2006; Multidrug-resistant and extended-spectrum β -lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis 10:434–438 [CrossRef]
    [Google Scholar]
  13. Renuka K., Sood S., Das B. K., Kapil A. 2005; High-level ciprofloxacin resistance in Salmonella enterica serovar Typhi in India. J Med Microbiol 54:999–1000 [CrossRef]
    [Google Scholar]
  14. Richardson D. C., Bast D., McGeer A., Low D. E. 2001; Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae . Antimicrob Agents Chemother 45:1911–1914 [CrossRef]
    [Google Scholar]
  15. Saha S. K., Talukder S. Y., Islam M., Saha S. 1999; A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J 18:387 [CrossRef]
    [Google Scholar]
  16. Saha S. K., Darmstadt G. L., Baqui A. H., Crook D. W., Islam M. N., Islam M., Hossain M., Arifeen S. E., Santoshan M., Black R. E. 2006; Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh. J Clin Microbiol 44:3811–3813 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47353-0
Loading
/content/journal/jmm/10.1099/jmm.0.47353-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error